Genetic liability to gastro-esophageal reflux disease, obesity, and risk of idiopathic pulmonary fibrosis.

[1]  Y. Kanwar,et al.  New Pandemic: Obesity and Associated Nephropathy , 2021, Frontiers in Medicine.

[2]  S. Suissa,et al.  Effectiveness of proton pump inhibitors in idiopathic pulmonary fibrosis: a population-based cohort study. , 2020, Chest.

[3]  M. Munafo,et al.  Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study , 2019, Psychological Medicine.

[4]  A. Auton,et al.  Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases , 2019, Nature Communications.

[5]  Vilmundur Gudnason,et al.  Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis , 2019, bioRxiv.

[6]  Samuel E. Jones,et al.  Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry , 2018, bioRxiv.

[7]  A. Hayen,et al.  Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry , 2017, European Respiratory Journal.

[8]  F. Herth,et al.  Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. , 2016, The Lancet. Respiratory medicine.

[9]  G. Davey Smith,et al.  Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.

[10]  Augustine S. Lee,et al.  The burden of idiopathic pulmonary fibrosis: an unmet public health need. , 2014, Respiratory medicine.

[11]  Laura E Nagy,et al.  Obesity, diabetes mellitus, and liver fibrosis. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[12]  Y. Lacasse,et al.  Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis , 2019, Chest.